JPS5141359A - - Google Patents

Info

Publication number
JPS5141359A
JPS5141359A JP50096317A JP9631775A JPS5141359A JP S5141359 A JPS5141359 A JP S5141359A JP 50096317 A JP50096317 A JP 50096317A JP 9631775 A JP9631775 A JP 9631775A JP S5141359 A JPS5141359 A JP S5141359A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50096317A
Other languages
Japanese (ja)
Inventor
Keenitsuhi Borufugangu
Gaigaa Rorufu
Kuruto Zando Yurugen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5141359A publication Critical patent/JPS5141359A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP50096317A 1974-08-09 1975-08-09 Pending JPS5141359A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438352A DE2438352A1 (de) 1974-08-09 1974-08-09 Peptidcyclopropylamide mit lh-rh/fshrh-wirkung

Publications (1)

Publication Number Publication Date
JPS5141359A true JPS5141359A (enrdf_load_stackoverflow) 1976-04-07

Family

ID=5922834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50096317A Pending JPS5141359A (enrdf_load_stackoverflow) 1974-08-09 1975-08-09

Country Status (10)

Country Link
JP (1) JPS5141359A (enrdf_load_stackoverflow)
AU (1) AU8374575A (enrdf_load_stackoverflow)
BE (1) BE832311A (enrdf_load_stackoverflow)
DE (1) DE2438352A1 (enrdf_load_stackoverflow)
DK (1) DK361375A (enrdf_load_stackoverflow)
FR (1) FR2281133A1 (enrdf_load_stackoverflow)
IL (1) IL47879A0 (enrdf_load_stackoverflow)
LU (1) LU73168A1 (enrdf_load_stackoverflow)
NL (1) NL7509259A (enrdf_load_stackoverflow)
SE (1) SE7508927L (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59194069U (ja) * 1983-06-08 1984-12-24 大日本印刷株式会社 尿検査用カツプ
JPS6041859U (ja) * 1983-08-29 1985-03-25 栄研化学株式会社 血液診断用分析試験片
EP0779072A1 (en) 1995-12-15 1997-06-18 Takeda Chemical Industries, Ltd. Production of microspheres
EP0781548A2 (en) 1995-12-15 1997-07-02 Takeda Chemical Industries, Ltd. Production of sustained-release preparation for injection
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DK1575569T3 (da) 2002-12-13 2011-01-10 Durect Corp Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
PT2767292T (pt) 2004-09-17 2016-11-23 Durect Corp Composição anestésica local prolongada contendo aibs
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
PL2117521T3 (pl) 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59194069U (ja) * 1983-06-08 1984-12-24 大日本印刷株式会社 尿検査用カツプ
JPS6041859U (ja) * 1983-08-29 1985-03-25 栄研化学株式会社 血液診断用分析試験片
EP0779072A1 (en) 1995-12-15 1997-06-18 Takeda Chemical Industries, Ltd. Production of microspheres
EP0781548A2 (en) 1995-12-15 1997-07-02 Takeda Chemical Industries, Ltd. Production of sustained-release preparation for injection
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents

Also Published As

Publication number Publication date
FR2281133A1 (fr) 1976-03-05
DK361375A (da) 1976-02-10
BE832311A (fr) 1976-02-11
NL7509259A (nl) 1976-02-11
IL47879A0 (en) 1975-11-25
SE7508927L (sv) 1976-02-10
DE2438352A1 (de) 1976-02-26
LU73168A1 (enrdf_load_stackoverflow) 1977-04-13
AU8374575A (en) 1977-02-10

Similar Documents

Publication Publication Date Title
DK137178C (enrdf_load_stackoverflow)
DK432875A (enrdf_load_stackoverflow)
DK135875A (enrdf_load_stackoverflow)
FI751836A7 (enrdf_load_stackoverflow)
JPS5141359A (enrdf_load_stackoverflow)
FR2261969B1 (enrdf_load_stackoverflow)
FR2263195A1 (enrdf_load_stackoverflow)
FR2263161B1 (enrdf_load_stackoverflow)
FR2262350A1 (enrdf_load_stackoverflow)
FR2257723B3 (enrdf_load_stackoverflow)
FI167074A7 (enrdf_load_stackoverflow)
FI372374A7 (enrdf_load_stackoverflow)
CS174526B1 (enrdf_load_stackoverflow)
BG20459A1 (enrdf_load_stackoverflow)
AU480559A (enrdf_load_stackoverflow)
BG20673A1 (enrdf_load_stackoverflow)
BG20672A1 (enrdf_load_stackoverflow)
BG20653A1 (enrdf_load_stackoverflow)
BG20518A1 (enrdf_load_stackoverflow)
BG20517A1 (enrdf_load_stackoverflow)
BG20516A1 (enrdf_load_stackoverflow)
BG20473A1 (enrdf_load_stackoverflow)
BG20464A1 (enrdf_load_stackoverflow)
BG20461A1 (enrdf_load_stackoverflow)
CH587623A5 (enrdf_load_stackoverflow)